Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma

Pokaži ostale verzije (1)

Background and purpose: Tumour hypoxia is associated with a poor prognosis in head and neck squamous cell carcinoma (HNSCC), however there is no accepted method for assessing hypoxia clinically. We aimed to conduct a technical validation of a hypoxia gene expression signature using the TaqMan Low De...

Bibliografski detalji
Glavni autori:	Betts, G, Eustace, A, Patiar, S, Valentine, H, Irlam, J, Ramachandran, A, Merve, A, Homer, J, Möller-Levet, C, Buffa, F, Hall, G, Miller, C, Harris, A, West, C
Format:	Journal article
Jezik:	English
Izdano:	2013

Slični predmeti

Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma.
od: Betts, G, i dr.
Izdano: (2013)

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis
od: Moller-Levet, C, i dr.
Izdano: (2009)

hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer.
od: Gee, H, i dr.
Izdano: (2010)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3.
od: Ramachandran, A, i dr.
Izdano: (2013)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3
od: Ramachandran, A, i dr.
Izdano: (2013)

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
od: Eustace, A, i dr.
Izdano: (2013)

Gene expression signatures as biomarkers of tumour hypoxia
od: Harris, B, i dr.
Izdano: (2015)

Expression of miR-210 in relation to other measures of hypoxia and prediction of benefit from hypoxia modification in patients with bladder cancer
od: Irlam-Jones, J, i dr.
Izdano: (2016)

Exon array analysis of head and neck cancers identifies a hypoxia related splice variant of LAMA3 associated with a poor prognosis.
od: Carla S Moller-Levet, i dr.
Izdano: (2009-11-01)

Spectral clustering of microarray data elucidates the roles of microenvironment remodeling and immune responses in survival of head and neck squamous cell carcinoma.
od: Thurlow, J, i dr.
Izdano: (2010)

A gene signature for selecting benefit from hypoxia modification of radiotherapy for high risk bladder cancer patients
od: Yang, L, i dr.
Izdano: (2017)

Relation of a hypoxia metagene derived from head and neck cancer to prognosis of multiple cancers.
od: Winter, S, i dr.
Izdano: (2007)

Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
od: Okonjo, FA, i dr.
Izdano: (2009)

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis
od: Gee, H, i dr.
Izdano: (2011)

The small-nucleolar RNAs commonly used for microRNA normalisation correlate with tumour pathology and prognosis.
od: Gee, H, i dr.
Izdano: (2011)

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
od: Jubb, A, i dr.
Izdano: (2010)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial
od: Eustace, A, i dr.
Izdano: (2013)

Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial.
od: Eustace, A, i dr.
Izdano: (2013)

Circulating tumour DNA detects somatic variants contributing to spatial and temporal intra-tumoural heterogeneity in head and neck squamous cell carcinoma
od: Karl F. B. Payne, i dr.
Izdano: (2024-04-01)

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
od: Ashton, T, i dr.
Izdano: (2016)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.
od: Buffa, F, i dr.
Izdano: (2010)

Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
od: Haider, S, i dr.
Izdano: (2016)

Impact of Tumour Hypoxia on Evofosfamide Sensitivity in Head and Neck Squamous Cell Carcinoma Patient-Derived Xenograft Models
od: Julia K. Harms, i dr.
Izdano: (2019-07-01)

Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models
od: Tet Woo Lee, i dr.
Izdano: (2024-08-01)

Combining hypoxia-activated prodrugs and radiotherapy in silico: Impact of treatment scheduling and the intra-tumoural oxygen landscape.
od: Sara Hamis, i dr.
Izdano: (2020-08-01)

Targeting tumour hypoxia in breast cancer.
od: Milani, M, i dr.
Izdano: (2008)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene (British Journal of Cancer (2010) 102 (428435) DOI:10.1038/sj.bjc.6605450))
od: Buffa, F, i dr.
Izdano: (2010)

The tumour hypoxia induced non-coding transcriptome.
od: Choudhry, H, i dr.
Izdano: (2016)

The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
od: Thomas M. Ashton, i dr.
Izdano: (2016-07-01)

Erratum: Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene (British Journal of Cancer (2010) 102 (428-435) DOI: 10.1038/sj.bjc.6605450)
od: Buffa, F, i dr.
Izdano: (2010)

Radiation response and cure rate of human colon adenocarcinoma spheroids of different size: the significance of hypoxia on tumor control modelling.
od: Buffa, F, i dr.
Izdano: (2001)

Increasing radiosensitivity by alleviating tumour hypoxia: a drug screen reveals atovaquone as a clinical candidate
od: Ashton, T, i dr.
Izdano: (2016)

Intra-Abdominal Desmoid Tumour (DT) with Pelvic Extension-A Case Report
od: Sathish Selva Kumar, i dr.
Izdano: (2014-01-01)

Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours
od: Kamilla JA. Bigos, i dr.
Izdano: (2024-01-01)

Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density.
od: Beasley, N, i dr.
Izdano: (2001)

Reducing tumour hypoxia via oral administration of oxygen nanobubbles
od: Owen, J, i dr.
Izdano: (2016)

Oxygen-enhanced MRI assessment of tumour hypoxia in head and neck cancer is feasible and well tolerated in the clinical setting
od: Alastair McCabe, i dr.
Izdano: (2024-03-01)

Long term survival following the detection of circulating tumour cells in head and neck squamous cell carcinoma
od: Winter, S, i dr.
Izdano: (2009)

Erratum: Radiation response and cure of human colon adenocarcinoma spheroids of different size: The significance of hypoxia tumor control modelling (International Journal of Radiation Oncology Biology Physics (2001) 49 (1109-1118))
od: Buffa, F, i dr.
Izdano: (2004)

Gene expression and hypoxia in breast cancer.
od: Favaro, E, i dr.
Izdano: (2011)